{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:32:09Z","timestamp":1772584329739,"version":"3.50.1"},"reference-count":41,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,10,30]]},"DOI":"10.1248\/bpb.b25-00513","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:06:30Z","timestamp":1761775590000},"page":"1621-1633","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Resmetirom on Resistance to Thyroid Hormone Receptor Mutants: Potential Basis for Therapeutic Applications"],"prefix":"10.1248","volume":"48","author":[{"given":"Mana","family":"Mitsutani","sequence":"first","affiliation":[{"name":"Medicine &amp; Clinical Science, Faculty of Pharmaceutical Sciences, Mukogawa Women\u2019s University, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Hano","sequence":"additional","affiliation":[{"name":"Medicine &amp; Clinical Science, Faculty of Pharmaceutical Sciences, Mukogawa Women\u2019s University, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Medicine &amp; Clinical Science, Faculty of Pharmaceutical Sciences, Mukogawa Women\u2019s University, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Medicine &amp; Clinical Science, Faculty of Pharmaceutical Sciences, Mukogawa Women\u2019s University, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tagami","sequence":"additional","affiliation":[{"name":"Clinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Kyoto 612\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Medicine &amp; Clinical Science, Faculty of Pharmaceutical Sciences, Mukogawa Women\u2019s University, Hyogo 663\u20138179, Japan"},{"name":"Clinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Kyoto 612\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. <i>Best Pract. Res. Clin. Endocrinol. Metab.<\/i>, <b>21<\/b>, 277\u2013305 (2007).","DOI":"10.1016\/j.beem.2007.03.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dumitrescu AM, Refetoff S. The syndromes of reduced sensitivity to thyroid hormone. <i>Biochim. Biophys. Acta, Gen. Subj.<\/i>, <b>1830<\/b>, 3987\u20134003 (2013).","DOI":"10.1016\/j.bbagen.2012.08.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Saponaro F, Sestito S, Runfola M, Rapposelli S, Chiellini G. Selective thyroid hormone receptor-beta (TR\u03b2) agonists: new perspectives for the treatment of metabolic and neurodegenerative disorders. <i>Front. Med.<\/i>, <b>7<\/b>, 331 (2020).","DOI":"10.3389\/fmed.2020.00331"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mitsutani M, Yokoyama M, Hano H, Morita A, Matsushita M, Tagami T, Moriyama K. Resmetirom is an effective thyromimetics for the chemical rescue of thyroid hormone receptor mutants. <i>Biol. Pharm. Bull.<\/i>, <b>48<\/b>, 463\u2013474 (2025).","DOI":"10.1248\/bpb.b24-00845"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Yatsuga S, Hiromatsu Y, Sasaki S, Nakamura H, Katayama K, Nishioka J, Koga Y. A two-day-old hyperthyroid neonate with thyroid hormone resistance born to a mother with well-controlled Graves\u2019 disease: a case report. <i>J. Med. Case Rep.<\/i>, <b>6<\/b>, 246 (2012).","DOI":"10.1186\/1752-1947-6-246"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ohba K, Sasaki S, Misawa Nakamura H, Matsushita A, Kuroda G, Sakai Y, Nakamura H. Clinical outcomes of 34 patients with resistance to thyroid hormone beta: a twenty-year experience in Japan. <i>Endocr. J.<\/i>, <b>69<\/b>, 179\u2013188 (2022).","DOI":"10.1507\/endocrj.EJ21-0390"},{"key":"7","unstructured":"7) \u201cThe Japan Medical Abstract Society database.\u201d: &lt;https:\/\/search.jamas.or.jp\/&gt;, accessed 1 July, 2025."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shiwa T, Oki K, Awaya T, Nakanishi S, Yamane K. Resistance to thyroid hormone accompanied by Graves\u2019 disease. <i>Intern. Med.<\/i>, <b>50<\/b>, 1977\u20131980 (2011).","DOI":"10.2169\/internalmedicine.50.4904"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sato H, Tomita Y. Resistance to thyroid hormone accompanied by atrial fibrillation. <i>Endocrinol. Diabetes Metab. Case Rep.<\/i>, 18\u20130100 (2018).","DOI":"10.1530\/EDM-18-0100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ito J, Narumi S, Nishizawa K, Kamimaki T, Hori N, Hasegawa T. A novel mutation of the THRB gene in a Japanese family with resistance to thyroid hormone. <i>Clin. Pediatr. Endocrinol.<\/i>, <b>25<\/b>, 19\u201322 (2016).","DOI":"10.1297\/cpe.25.19"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kimura T, Hayashi Y, Tsukamoto Y, Okamoto Y. The mutant thyroid hormone receptor beta R320P causes syndrome of resistance to thyroid hormone. <i>Case Rep. Endocrinol.<\/i>, <b>2018<\/b>, 4081769 (2018).","DOI":"10.1155\/2018\/4081769"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Taniyama M, Ban Y, Momotani N, Makino F, Ito K, Ban Y. Three Japanese patients from two families with generalized resistance to thyroid hormone with mutations in exon 9 of the thyroid hormone receptor beta gene. <i>Intern. Med.<\/i>, <b>40<\/b>, 756\u2013758 (2001).","DOI":"10.2169\/internalmedicine.40.756"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hatano M, Tanase-Nakao K, Uehara E, Iwano R, Muroya K, Narumi S. Concurrent THRB and DUOX2 variants in a patient detected <i>via<\/i> newborn screening for congenital hypothyroidism: a case of resistance to thyroid hormone. <i>Clin. Pediatr. Endocrinol.<\/i>, <b>33<\/b>, 94\u2013100 (2024).","DOI":"10.1297\/cpe.2023-0059"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sato H, Koike Y, Honma M, Yagame M, Ito K. Evaluation of thyroid hormone action in a case of generalized resistance to thyroid hormone with chronic thyroiditis: discovery of a novel heterozygous missense mutation (G347A). <i>Endocr. J.<\/i>, <b>54<\/b>, 727\u2013732 (2007).","DOI":"10.1507\/endocrj.K07-014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Narumi S, Cho H, Tamada I, Kozu Y, Tsuchiya T, Nagai T, Hasegawa T. One novel and two recurrent THRB mutations associated with resistance to thyroid hormone: structure-based computational mutation prediction. <i>Clin. Pediatr. Endocrinol.<\/i>, <b>19<\/b>, 91\u201399 (2010).","DOI":"10.1297\/cpe.19.91"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sato H. Clinical features of primary hyperthyroidism caused by Graves\u2019 disease admixed with resistance to thyroid hormone (P453T). <i>Endocr. J.<\/i>, <b>57<\/b>, 687\u2013692 (2010).","DOI":"10.1507\/endocrj.K10E-066"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sato H, Sakai H. A family showing resistance to thyroid hormone associated with chronic thyroiditis and its clinical features: a case report. <i>Endocr. J.<\/i>, <b>53<\/b>, 421\u2013425 (2006).","DOI":"10.1507\/endocrj.K05-182"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kelly MJ, Pietranico-Cole S, Larigan JD, Haynes NE, Reynolds CH, Scott N, Vermeulen J, Dvorozniak M, Conde-Knape K, Huang KS, So SS, Thakkar K, Qian Y, Banner B, Mennona F, Danzi S, Klein I, Taub R, Tilley J. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a highly selective thyroid hormone receptor \u03b2 agonist in clinical trials for the treatment of dyslipidemia. <i>J. Med. Chem.<\/i>, <b>57<\/b>, 3912\u20133923 (2014).","DOI":"10.1021\/jm4019299"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hayashi Y, Sunthornthepvarakul T, Refetoff S. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. <i>J. Clin. Invest.<\/i>, <b>94<\/b>, 607\u2013615 (1994).","DOI":"10.1172\/JCI117376"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. <i>Genome Biol.<\/i>, <b>5<\/b>, R31 (2004).","DOI":"10.1186\/gb-2004-5-5-r31"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhang XY, Kaneshige M, Kamiya Y, Kaneshige K, McPhie P, Cheng SY. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant beta receptor. <i>Mol. Endocrinol.<\/i>, <b>16<\/b>, 2077\u20132092 (2002).","DOI":"10.1210\/me.2002-0080"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nagaya T, Madison LD, Jameson JL. Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes. <i>J. Biol. Chem.<\/i>, <b>267<\/b>, 13014\u201313019 (1992).","DOI":"10.1016\/S0021-9258(18)42375-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nagaya T, Jameson JL. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. <i>J. Biol. Chem.<\/i>, <b>268<\/b>, 15766\u201315771 (1993).","DOI":"10.1016\/S0021-9258(18)82321-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Matsushita A, Misawa H, Andoh S, Natsume H, Nishiyama K, Sasaki S, Nakamura H. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT. <i>J. Endocrinol.<\/i>, <b>167<\/b>, 493\u2013503 (2000).","DOI":"10.1677\/joe.0.1670493"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Clifton-Bligh RJ, de Zegher F, Wagner RL, Collingwood TN, Francois I, Van Helvoirt M, Fletterick RJ, Chatterjee VK. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. <i>Mol. Endocrinol.<\/i>, <b>12<\/b>, 609\u2013621 (1998).","DOI":"10.1210\/mend.12.5.0113"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tagami T, Gu WX, Peairs PT, West BL, Jameson JL. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. <i>Mol. Endocrinol.<\/i>, <b>12<\/b>, 1888\u20131902 (1998).","DOI":"10.1210\/mend.12.12.0201"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I\/LXXII) that serve as receptor interaction domains (IDs). <i>Mol. Endocrinol.<\/i>, <b>14<\/b>, 1976\u20131985 (2000).","DOI":"10.1210\/mend.14.12.0566"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hu X, Lazar MA. Transcriptional repression by nuclear hormone receptors. <i>Trends Endocrinol. Metab.<\/i>, <b>11<\/b>, 6\u201310 (2000).","DOI":"10.1016\/S1043-2760(99)00215-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) S\u00e1nchez-Mart\u00ednez R, Zambrano A, Castillo AI, Aranda A. Vitamin D-dependent recruitment of corepressors to vitamin D\/retinoid X receptor heterodimers. <i>Mol. Cell. Biol.<\/i>, <b>28<\/b>, 3817\u20133829 (2008).","DOI":"10.1128\/MCB.01909-07"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Harrus D, D\u00e9m\u00e9n\u00e9 H, Vasquez E, Boulahtouf A, Germain P, Figueira AC, Privalsky ML, Bourguet W, le Maire A. Pathological interactions between mutant thyroid hormone receptors and corepressors and their modulation by a thyroid hormone analogue with therapeutic potential. <i>Thyroid<\/i>, <b>28<\/b>, 1708\u20131722 (2018).","DOI":"10.1089\/thy.2017.0551"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Phelan CA, Gampe RT Jr, Lambert MH, Parks DJ, Montana V, Bynum J, Broderick TM, Hu X, Williams SP, Nolte RT, Lazar MA. Structure of Rev-erb\u03b1 bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction. <i>Nat. Struct. Mol. Biol.<\/i>, <b>17<\/b>, 808\u2013814 (2010).","DOI":"10.1038\/nsmb.1860"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chiamolera MI, Wondisford FE. Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. <i>Endocrinology<\/i>, <b>150<\/b>, 1091\u20131096 (2009).","DOI":"10.1210\/en.2008-1795"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Tone Y, Collingwood TN, Adams M, Chatterjee VK. Functional analysis of a transactivation domain in the thyroid hormone beta receptor. <i>J. Biol. Chem.<\/i>, <b>269<\/b>, 31157\u201331161 (1994).","DOI":"10.1016\/S0021-9258(18)47403-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, O\u2019Malley BW. The t4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. <i>Mol. Cell. Biol.<\/i>, <b>15<\/b>, 76\u201386 (1995).","DOI":"10.1128\/MCB.15.1.76"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) LaFranchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA, Nelson JC. Follow-up of newborns with elevated screening T4 concentrations. <i>J. Pediatr.<\/i>, <b>143<\/b>, 296\u2013301 (2003).","DOI":"10.1067\/S0022-3476(03)00184-7"},{"key":"36","unstructured":"36) Statistics Bureau of Japan. \u201cCurrent Population Estimates as of October 1, 2023.\u201d: &lt;https:\/\/www.stat.go.jp\/english\/data\/jinsui\/2023np\/index.html#a15k01-a&gt;, accessed 1 July, 2025."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Tagami T. An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders. <i>Endocr. J.<\/i>, <b>68<\/b>, 509\u2013517 (2021).","DOI":"10.1507\/endocrj.EJ21-0059"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Okosieme OE, Usman D, Taylor PN, Dayan CM, Lyons G, Moran C, Chatterjee K, Rees DA. Cardiovascular morbidity and mortality in patients in Wales, U.K. with resistance to thyroid hormone \u03b2 (RTH\u03b2): a linked-record cohort study. <i>Lancet Diabetes Endocrinol.<\/i>, <b>11<\/b>, 657\u2013666 (2023).","DOI":"10.1016\/S2213-8587(23)00155-9"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Campi I, Censi S, Prodam F, Petrone L, Brigante G, Porcelli T, Ruggeri RM, Vigone MC, Rurale G, Lio S, Pelusi C, Persani L. Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone \u03b2 (RTH\u03b2). <i>Eur. J. Endocrinol.<\/i>, <b>191<\/b>, 407\u2013415 (2024).","DOI":"10.1093\/ejendo\/lvae117"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Nascimento AS, Dias SMG, Nunes FM, Aparicio R, Ambrosio ALB, Bleicher L, Figueira ACM, Santos MAM, de Oliveira Neto M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov I. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. <i>J. Mol. Biol.<\/i>, <b>360<\/b>, 586\u2013598 (2006).","DOI":"10.1016\/j.jmb.2006.05.008"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity. <i>J. Mol. Endocrinol.<\/i>, <b>42<\/b>, 415\u2013428 (2009).","DOI":"10.1677\/JME-08-0153"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00513\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:24:07Z","timestamp":1761967447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b25-00513\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00513","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"b25-00513"}}